O. Pol et al., THE INHIBITORY EFFECTS OF ALPHA(2)-ADRENOCEPTOR AGONISTS ON GASTROINTESTINAL TRANSIT DURING CROTON OIL-INDUCED INTESTINAL INFLAMMATION, British Journal of Pharmacology, 119(8), 1996, pp. 1649-1655
1 The peripheral effects of az-adrenoceptor agonists were investigated
in a model of intestinal inflammation induced by intragastric adminis
tration of croton oil (GO). Our hypothesis was that inflammation would
'sensitize' adrenoceptors in peripheral and/or central terminals of m
yenteric and submucous plexus neurones, and enhance systemic effects o
f alpha(2)-adrenoceptor agonists. 2 Male swiss CD-1 mice, received int
ragastrically CO (0.05 ml), castor oil (CA, 0.1 ml) or saline (SS) 3 h
before the study: gastrointestinal transit (GIT) was evaluated 20 min
afterwards with a charcoal meal. The presence of inflammation was ass
essed by electron microscopy. 3 The intragastric administration of CA
or CO caused an increase in GIT and weight loss, but only CO induced a
n inflammatory response. Both clonidine (imidazoline(1)/alpha(2)-agoni
st) and UK-14304 (alpha(2)-agonist) produced dose-related inhibitions
of GIT in all groups. During inflammatory diarrhoea (GO), potencies of
systemic (s.c.) clonidine and UK-14304 were significantly increased 3
.5 and 2.1 times, respectively, while potencies remained unaltered in
the presence of diarrhoea without inflammation (CA). The effects were
reversed by administration (s.c.) of receptor-specific adrenoceptor an
tagonists, but not by naloxone. 4 Clonidine was 8.3 (SS) and 2.8 (CO)
times more potent when administered intracerebroventricularly (i.c.v.)
, than when administered s.c. Inflammation of the gut did not alter th
e potency of i.c.v. clonidine, demonstrating that enhanced effects of
s.c. clonidine are mediated by peripheral receptors. During inflammati
on, i.c.v. efaroxan did not antagonize low doses of s.c. clonidine (ED
(20) and ED(50)s), but partially reversed ED(80)s, further supporting
the peripheral effects of the agonists in CO treated animals. 5 The re
sults demonstrate that inflammation of the gut enhances the potency of
alpha(2)-adrenoceptor agonists by a peripheral mechanism. The results
also suggest that the inflammatory response induces an up-regulation
or sensitization of alpha(2)-adrenoceptors and/or imidazoline receptor
s.